TGFB1 and neoplasm: In this context, the TGFβ-docking receptor glycoprotein A repetitions-predominant (GARP)–TGF-β axis plays a pivotal role in tumor immune evasion by activating latent TGF-β on platelets and Tregs, thus promoting immune suppression and tumor progression [28,29,30].